About Zynex
Zynex is a company based in Lone Tree (United States) founded in 1996. The company has 1,000 employees. Zynex has completed 2 acquisitions, including Kestrel Labs and NeuroDyne Medical. Zynex offers products and services including NexWave, Zynex Pro LSO Braces, Zynex Pro OA Knee Brace, and Saunders CT. Zynex operates in a competitive market with competitors including Noctrix Health, Neurovalens, Brain in Hand, Trexo Robotics and Neurofenix, among others.
- Annual Revenue$192.35 M (USD)4.36as on Dec 31, 2024
- Net Profit$2.99 M (USD)-69.24as on Dec 31, 2024
- EBITDA$10.77 M (USD)-28.19as on Dec 31, 2024
- Latest Funding Round$696K (USD), Post-IPO
Jan 2007
- Employee Count1,000
- Investments & AcquisitionsKestrel Labs
& 1 more
Products & Services of Zynex
Zynex offers a comprehensive portfolio of products and services, including NexWave, Zynex Pro LSO Braces, Zynex Pro OA Knee Brace, and Saunders CT.
Prescription device for IFC, TENS, and NMES to manage debilitating pain.
Braces providing relief for secondary back pain and lateral support.
Brace offering superior relief for knee pain from osteoarthritis.
Device for safe, effective home traction to alleviate neck pain.
Apps and channels of Zynex
its YouTube channel Zynex Medical has 1.75K subscribers and 8 videos.
Videos from Zynex
The most watched videos on Zynex's YouTube channel, Zynex Medical (1.75K subscribers). Click a video to play it here.
More on Zynex Medical.
Funding Insights of Zynex
- Total Rounds 2
- Last Round Post-IPO — $696,000
- First Round $275,000
(Oct 2006)
All 2 funding rounds of Zynex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2007 | $696,000 | Post-IPO | – | – | – |
| Oct 2006 | $275,000 | Debt – Conventional | – | – | – |
People of Zynex
190 people are tracked at Zynex (13 in leadership, 3 in board & advisors, 174 in team); the tracked headcount is 1,000.
| Name | Role | Group |
|---|---|---|
Anna Lucsok | VP of Reimbursement | Leadership |
Chelle Van Burkleo | VP of Sales | Leadership |
Thomas Sandgaard | Chairman, President and Chief Executive Officer | Leadership |
Haley Parker | Vice President Of Sales | East | Leadership |
Todd Loewe | Western Regional Sales Director | Leadership |
Dave Anttila Mba | Director Of Human Resources | Leadership |
Nick Johnson | Regional Sales Director | Leadership |
Wendy Verts | Director Of Payer Relations | Leadership |
Steve Benasso | Head Of Human Resources | Leadership |
Morez Gutierrez | Head Of Talent Acquisition | Leadership |
Claudia Schmidt Brazel | National Accounts Director | Leadership |
Thao le | Vice President Of Reimbursement | Leadership |
Addy Cooper | Chief Of Staff | Leadership |
Barry Michaels | Director | Board & advisors |
Michael Cress | Director | Board & advisors |
Josh Disbrow | Director | Board & advisors |
Glenda Pearce | Territory Manager | Team |
Kyle Landis | Territory Manager | Team |
Doug Dawkins | Territory Manager | Team |
Dawn Lindsey | Area Sales Manager | Team |
170 more people are available in the full profile.
Complete people profiles for Zynex
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Zynex
Zynex is a publicly listed company on the NASDAQ with ticker symbol ZYXI in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date30 Jul 2012
- Listed onNASDAQ: ZYXI
- Listed entityZynex, Inc.
- Exchange sectorHealth technology
- ISINUS98986M1036
- Share price$0.12 (-34.9% on the day) · 2025-12-24
- Market capitalisation$3.8M
- EPS (diluted, trailing year)$-2.43
- Volume (last session)32,283,341
- Analyst consensusNeutral
Financials of Zynex
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2024 | $192.3M | $3.0M | $10.8M |
| 2023 | $184.3M | $9.7M | $15.0M |
| 2022 | $158.2M | $17.1M | $26.9M |
| 2021 | $130.3M | $17.1M | $26.1M |
| 2020 | $80.1M | $9.1M | $11.8M |
Detailed financial statements for Zynex
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zynex
Zynex has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Kestrel Labs and NeuroDyne Medical.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Photoplethysmography monitoring devices are manufactured by Kestrel Labs. | kestrellabs.com | United States | 2001 | Dec 2021 | •••• | |
Manufacturer of medical instruments and disposable electrodes | neurodynemedical.com | Cambridge, United States | 1993 | Mar 2012 | $420,000 |
Complete acquisition details for Zynex
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Zynex
6 dated milestones of Zynex across 25 years, from founding to its latest funding, stage changes and deals.
- Founded Zynex is founded.
- Funding First funding round of $275K.
- Funding Latest funding round, Post-IPO, of $696K.
- Acquisition Acquires NeuroDyne Medical.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Kestrel Labs.
Competitors of Zynex
Zynex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Noctrix Health, Neurovalens, Brain in Hand, Trexo Robotics and Neurofenix, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| noctrixhealth.com | 2016 | San Francisco, United States | $90.5M | 8 | Wearable therapeutic devices for neurological disorders are developed. | |
| neurovalens.com | 2013 | Belfast, United Kingdom | $26.12M | 22 | A headset-like device for obesity treatment is developed by Neurovalens. | |
| braininhand.co.uk | 2009 | Exeter, United Kingdom | $1.02M | 136 | Assistive technology is developed for impaired executive brain functions. | |
| trexorobotics.com | 2016 | Mississauga, Canada | $1.54M | – | Battery-operated exoskeletons for children with disabilities are developed. | |
| neurofenix.com | 2016 | London, United Kingdom | $7M | 13 | Medical devices for neurorehabilitation are manufactured for therapy sessions. | |
| thinkhumm.com | 2019 | San Francisco, United States | $2.6M | – | Wearable patch for brain stimulation | |
| platoscience.com | 2015 | Copenhagen, Denmark | $615,251 | 7 | A plug-and-play neurostimulation headset is provided for brain enhancement. | |
| dynofit.com | 2011 | Los Alamos, United States | – | – | Wearable EMG sensor for rehabilitation |
Detailed competitors of Zynex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Zynex
The website of Zynex (zynex.com) receives about 18.1K visits a month.
- Monthly visits18.1K
▼ 9.6% vs previous month
Websites whose visitors overlap most with Zynex. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
rosenlegal.com | rosenlegal.com | 100% | – | #431,047 | – |
Latest news on Zynex
Complete news archive for Zynex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Zynex
10 companies that operate in the same segment as Zynex (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | – | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Zynex
Zynex was founded in 1996 and raised its 1st funding round 10 years after it was founded.
Zynex is headquartered in Lone Tree, United States. It is registered at Lone Tree, Colorado, United States.
Zynex has 1,000 employees.
Annual revenue of Zynex is $192.35M as on Dec 31, 2024.
Zynex was founded in 1996 and is headquartered in Lone Tree, United States. Operations focus on the medical devices sector, with non-invasive products developed for electrotherapy and stroke rehabilitation. Three segments are maintained: Zynex Medical for home-use electrotherapy, Zynex Monitoring Solutions for hospital cardiac monitoring, and Zynex NeuroDiagnostics for EMG and EEG diagnostics in neurology.
Zynex's top competitors include Neurovalens, Noctrix Health and Brain in Hand.
Zynex offers NexWave, Zynex Pro LSO Braces, Zynex Pro OA Knee Brace, and Saunders CT.
Yes, Zynex is publicly traded on NASDAQ under the ticker symbol ZYXI.
Zynex has made 2 acquisitions, including Kestrel Labs, and NeuroDyne Medical.